PHASE I/IB STUDY OF LONAFARNIB AND TEMOZOLOMIDE IN PATIENTS WITH RECURRENT OR TEMOZOLOMIDE REFRACTORY GLIOBLASTOMA

被引：0
|
作者：
Yust-Katz, Shlomit [1 ]
Liu, Vivian [1 ]
Sanghee, Kang [1 ]
Groves, Moriss [1 ]
Puduvalli, Vinay [1 ]
Levin, Victor [1 ]
Conrad, Charles [1 ]
Colman, Howard [2 ]
Hsu, Sigmund [1 ]
Yung, Alfred W. [1 ]
Gilbert, Mark R. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [41] Bevacizumab and daily temozolomide for recurrent glioblastoma
    Desjardins, Annick
    Reardon, David A.
    Coan, April
    Marcello, Jennifer
    Herndon, James E., II
    Bailey, Leighann
    Peters, Katherine B.
    Friedman, Henry S.
    Vredenburgh, James J.
    CANCER, 2012, 118 (05) : 1302 - 1312
  • [42] The efficacy of temozolomide for recurrent glioblastoma multiforme
    Chen, Chao
    Xu, Tao
    Lu, Yicheng
    Chen, Juxiang
    Wu, Shenhong
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (02) : 223 - 230
  • [43] Alternative regimen of temozolomide for recurrent glioblastoma
    Wick, Wolfgang
    Steinbach, Joachim P.
    Dichgans, Johannes
    Bamberg, Michael
    Weller, Michael
    ANNALS OF ONCOLOGY, 2004, 15 : 208 - 208
  • [44] A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors
    Jonathan Metts
    Brittany Harrington
    Emad Salman
    Scott M. Bradfield
    Jennifer Flanary
    Maua Mosha
    Ernest Amankwah
    Stacie Stapleton
    Child's Nervous System, 2022, 38 : 919 - 928
  • [45] A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors
    Metts, Jonathan
    Harrington, Brittany
    Salman, Emad
    Bradfield, Scott M.
    Flanary, Jennifer
    Mosha, Maua
    Amankwah, Ernest
    Stapleton, Stacie
    CHILDS NERVOUS SYSTEM, 2022, 38 (05) : 919 - 928
  • [46] Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
    Stupp, Roger
    Hegi, Monika E.
    Neyns, Bart
    Goldbrunner, Roland
    Schlegel, Uwe
    Clement, Paul M. J.
    Grabenbauer, Gerhard G.
    Ochsenbein, Adrian F.
    Simon, Matthias
    Dietrich, Pierre-Yves
    Pietsch, Torsten
    Hicking, Christine
    Tonn, Joerg-Christian
    Diserens, Annie-Claire
    Pica, Alessia
    Hermisson, Mirjam
    Krueger, Stefan
    Picard, Martin
    Weller, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2712 - 2718
  • [47] Phase I study of temozolomide in relapsed/refractory acute leukemia.
    Seiter, K
    Liu, DL
    Loughran, T
    Siddiqui, D
    Kancherla, R
    Ahmed, T
    BLOOD, 2001, 98 (11) : 222B - 222B
  • [48] MEVITEM-a phase I/II trial of vismodegib plus temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation
    Frappaz, Didier
    Barritault, Marc
    Montane, Laure
    Laigle-Donadey, Florence
    Chinot, Olivier
    Le Rhun, Emilie
    Bonneville-Levard, Alice
    Hottinger, Andreas F.
    Meyronnet, David
    Bidaux, Anne-Sophie
    Garin, Gwenaele
    Perol, David
    NEURO-ONCOLOGY, 2021, 23 (11) : 1949 - 1960
  • [49] Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma
    McCracken, D. Jay
    Celano, Emma C.
    Voloschin, Alfredo D.
    Read, William L.
    Olson, Jeffrey J.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (01) : 193 - 201
  • [50] Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
    Hunn, Martin K.
    Bauer, Evelyn
    Wood, Catherine E.
    Gasser, Olivier
    Dzhelali, Marina
    Ancelet, Lindsay R.
    Mester, Brigitta
    Sharples, Katrina J.
    Findlay, Michael P.
    Hamilton, David A.
    Hermans, Ian F.
    JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 319 - 329
12345